COMPANY UPDATES
11
Dec
2017
Novoheart Profiled on CBC's Flagship News Program 'The National'

Novoheart is pleased to announce that an in-depth feature on the company and its technology was broadcast on Friday, December 8th on CBC News, Canada's largest news broadcaster.

05
Dec
2017
Novoheart Publishes Landmark Study Demonstrating the Use of Machine Learning to Accelerate Drug Screening

Novoheart announced the publication of its study in Stem Cell Reports, the official journal of the International Society for Stem Cell Research. The study demonstrates how machine learning technology can be leveraged to efficiently analyze rich data content generated from drug screening studies using Novoheart's bioengineered human heart tissues.

30
Nov
2017
Novoheart Files For Patent on Pioneering New Multi-organoid Bioreactor Platform

Novoheart announced that it has filed a provisional patent application with the United States Patent and Trademark Office (USPTO) for a versatile bioreactor platform that is used to culture, stimulate, and monitor the function of multiple engineered human-tissue organoids.

28
Nov
2017
Novoheart Holdings Inc. Reports First Quarter 2018 Financial Results

Novoheart announced financial results for the three months ended September 30, 2017. Amounts, unless specified otherwise, are expressed in Canadian dollars and are in accordance with International Financial Reporting Standards (IFRS).